Cargando…
Emerging treatment strategies for metastatic triple-negative breast cancer
Triple-negative breast cancer (TNBC) is a heterogeneous subtype of breast cancer that is often associated with an aggressive phenotype and a poor prognosis. Cytotoxic chemotherapy remains the mainstay of treatment for most patients with metastatic TNBC (mTNBC), but duration of response is often shor...
Autores principales: | Huppert, Laura A., Gumusay, Ozge, Rugo, Hope S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9003656/ https://www.ncbi.nlm.nih.gov/pubmed/35422881 http://dx.doi.org/10.1177/17588359221086916 |
Ejemplares similares
-
The role of percutaneous vertebral augmentation in patients with metastatic breast cancer: Literature review including report of two cases
por: Gumusay, Ozge, et al.
Publicado: (2022) -
Immunotherapy in Breast Cancer and the Potential Role of Liquid Biopsy
por: Magbanua, Mark Jesus M., et al.
Publicado: (2022) -
Emerging treatment options for the management of brain metastases in patients with HER2-positive metastatic breast cancer
por: Chien, A. Jo, et al.
Publicado: (2012) -
Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021) -
Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)